1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 23 Hits
  • Search Condition : Filter (MeSH = Prostatic Neoplasms / pathology)
Species Resource
DNA material pSTAT RE-TK hRluc(F) (RDB05616) , pISRE-TK hRluc(F) (RDB05610) , pGAS RE-TK hRluc(F) (RDB05624). Chondromodulin-1 directly suppresses growth of human cancer cells.
DNA material Ax1 CI-mIGIF (RDB01735) Cytosine deaminase-uracil phosphoribosyltransferase and interleukin (IL)-12 and IL-18: a multimodal anticancer interface marked by specific modulation in serum cytokines.
DNA material pCMV-MAZ pCMV-MAZi (RDB03219) Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells.
Mice TOP-GAL(RBRC02228) Differential requirements for β-catenin in murine prostate cancer originating from basal versus luminal cells.
C.elegans tm3976 FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
C.elegans tm3976 Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.
Human and Animal Cells LNCap.FGC(RCB2144) Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.
Human and Animal Cells MRMT-1(RCB2860) Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Human and Animal Cells PC-3(RCB2145) Galectin-9 induces atypical ubiquitination leading to cell death in PC-3 prostate cancer cells.
Human and Animal Cells Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Human and Animal Cells LNCap.FGC(RCB2144) Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
Human and Animal Cells DU145(RCB2143) Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
Human and Animal Cells LNCap.FGC(RCB2144) Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.
Human and Animal Cells ST2 (RCB0224) MLC-6 (RCB1536) Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
Human and Animal Cells DU145(RCB2143) Improving the bioavailability and anticancer effect of the PCA-1/ALKBH3 inhibitor HUHS015 using sodium salt.
Human and Animal Cells Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana.
Human and Animal Cells Development of human chorionic gonadotropin subunit-beta promoter-based toxic gene therapy for testicular cancer.
Human and Animal Cells Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.
Human and Animal Cells Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Human and Animal Cells Potent anticancer activities of novel aminophenol analogues against various cancer cell lines.